HSD17BX enzyme inhibitors (Organon & Co/Novartis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHSD17BX enzyme inhibitors (Organon & Co/Novartis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action17-hydroxysteroid dehydrogenases inhibitors
Targets17-hydroxysteroid dehydrogenases
Therapy Area/IndicationsLiver Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandFinland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrganon R&D Finland Oy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis AgOrganon R&D Finland OyOrganon & Co
Active IndicationsN/A
Inactive IndicationsLiver Diseases

Other Information

ATC CodeN/A
Related LinksN/A